Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.19.1
Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 3,268 $ (596,829) $ (403,992) $ (997,553)
Balance, shares at Dec. 31, 2017 3,268,005      
Equity-based compensation - stock option expense 69,161 69,161
Net Loss (378,950) (378,950)
Balance at Mar. 31, 2018 $ 3,268 (527,668) (782,942) (1,307,342)
Balance, shares at Mar. 31, 2018 3,268,005      
Balance at Dec. 31, 2018 $ 6,863 16,469,818 (12,035,370) 4,441,311
Balance, shares at Dec. 31, 2018 6,862,499      
Equity-based compensation - stock option expense 129,150 129,150
Equity-based compensation - stock issuances to consultants $ 94 154,760 154,854
Equity-based compensation - stock issuances to consultants, shares 93,750    
Warrant modification expense 441,763   441,763
Sale of Common Stock & Warrants $ 2,845 9,243,404 9,246,249
Sale of Common Stock & Warrants, shares 2,845,000    
Offering Issuance Cost (1,050,576) (1,050,576)
Exercise of warrants $ 367 1,050,270 1,050,637
Exercise of warrants, shares 367,577      
Net Loss (2,682,651) (2,682,651)
Balance at Mar. 31, 2019 $ 10,169 $ 26,438,589 $ (14,718,021) $ 11,730,737
Balance, shares at Mar. 31, 2019 10,168,826